Ayala Luria

AYALA LURIA, Ph.D, serves as the Head of Clinical Development and Medical Affairs at Starget Pharma since 2025 and is an advisor on Clinical Development, Medical Affairs, Radiopharmaceuticals, and Clinical Trials at Bracken. Luria has held the position of Clinical Development Lead for the U.S at ITM Isotope Technologies Munich SE since February 2023, and previously worked as Director of Field Clinical Science Liaison at Apollomics from January 2020 to March 2023. A background in medical affairs includes roles as Senior Medical Science Liaison at Novartis Oncology and Advanced Accelerator Applications, specializing in Oncology and Molecular Nuclear Medicine. Academic contributions include a Research Associate role at Stanford University focusing on autoimmune diseases and biomarker research, and a Professional Research Scientist position at University of California Davis, where Luria explored stem cell differentiation and treatments for bladder cancer. Luria holds a Ph.D. in Biochemistry & Molecular Biology from Bar-Ilan University and has received a Young Investigator award for research on smoke-induced lung inflammation.